Why is Aloe Blacc developing a cancer drug platform?

Following his experience contracting COVID-19 despite being vaccinated and boosted, Aloe Blacc is focusing on funding research and has initiated a cancer drug platform targeting pancreatic cancer.

What type of cancer is Aloe Blacc's drug platform targeting?

Aloe Blacc's cancer drug platform is intentionally targeting pancreatic cancer.

How is Aloe Blacc funding his cancer drug research?

Aloe Blacc is initially bootstrapping his cancer drug platform and plans to seek investment from his network only after peer-reviewed papers can make his case.

Home / Health / Aloe Blacc Tackles Pancreatic Cancer After COVID

Aloe Blacc Tackles Pancreatic Cancer After COVID

15 Apr

•

Summary

Singer Aloe Blacc aims to fund cancer research after his COVID experience.
He is building a pancreatic cancer drug platform.
Blacc is using a bootstrapping approach before seeking network investment.

Aloe Blacc Tackles Pancreatic Cancer After COVID

Grammy-nominated artist Aloe Blacc has embarked on a new venture in biotech following his personal experience with COVID-19, even after vaccination and boosting. He discovered that direct financial contributions to research are complex due to regulatory hurdles and licensing issues.

Consequently, Blacc is now actively developing a cancer drug platform with a specific focus on pancreatic cancer, a disease with a very high mortality rate. He is employing a bootstrapping strategy for this initiative.

His plan is to present peer-reviewed research to his network before seeking substantial investment, highlighting a deliberate approach to building scientific validation first.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.